NO923455L - Indolsulfonamidsubstituert dihydropyridin, fremgangsmaate for fremstilling og anvendelse i legemidler - Google Patents

Indolsulfonamidsubstituert dihydropyridin, fremgangsmaate for fremstilling og anvendelse i legemidler

Info

Publication number
NO923455L
NO923455L NO92923455A NO923455A NO923455L NO 923455 L NO923455 L NO 923455L NO 92923455 A NO92923455 A NO 92923455A NO 923455 A NO923455 A NO 923455A NO 923455 L NO923455 L NO 923455L
Authority
NO
Norway
Prior art keywords
indolsulphonamide
pharmaceuticals
procedures
production
substituted dihydropyridine
Prior art date
Application number
NO92923455A
Other languages
English (en)
Norwegian (no)
Other versions
NO923455D0 (no
Inventor
Ulrich Niewoehner
Siegfried Goldmann
Ulrich Mueller
Andreas Knorr
Elisabeth Perzborn
Matthias Schramm
Bernhard Beckermann
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of NO923455D0 publication Critical patent/NO923455D0/no
Publication of NO923455L publication Critical patent/NO923455L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO92923455A 1991-09-20 1992-09-04 Indolsulfonamidsubstituert dihydropyridin, fremgangsmaate for fremstilling og anvendelse i legemidler NO923455L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4131346A DE4131346A1 (de) 1991-09-20 1991-09-20 Indolsulfonamid substituierte dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln

Publications (2)

Publication Number Publication Date
NO923455D0 NO923455D0 (no) 1992-09-04
NO923455L true NO923455L (no) 1993-03-22

Family

ID=6441086

Family Applications (1)

Application Number Title Priority Date Filing Date
NO92923455A NO923455L (no) 1991-09-20 1992-09-04 Indolsulfonamidsubstituert dihydropyridin, fremgangsmaate for fremstilling og anvendelse i legemidler

Country Status (16)

Country Link
US (1) US5272161A (xx)
EP (1) EP0533014A1 (xx)
JP (1) JPH07215965A (xx)
KR (1) KR930006007A (xx)
CN (1) CN1070397A (xx)
AU (1) AU650781B2 (xx)
CA (1) CA2078498A1 (xx)
CZ (1) CZ286192A3 (xx)
DE (1) DE4131346A1 (xx)
FI (1) FI924167A (xx)
HU (1) HUT63160A (xx)
IL (1) IL103196A0 (xx)
MX (1) MX9205257A (xx)
NO (1) NO923455L (xx)
NZ (1) NZ244394A (xx)
ZA (1) ZA927154B (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001286542A1 (en) * 2000-08-18 2002-03-04 Genentech, Inc. Integrin receptor inhibitors
UA98777C2 (xx) * 2006-11-20 2012-06-25 Эли Лилли Энд Компани ТЕТРАГІДРОЦИКЛОПЕНТА$b]ІНДОЛИ ЯК МОДУЛЯТОРИ АНДРОГЕНОВИХ РЕЦЕПТОРІВ$ТЕТРАГИДРОЦИКЛОПЕНТА$b]ИНДОЛЫ КАК МОДУЛЯТОРЫ АНДРОГЕННЫХ РЕЦЕПТОРОВ
PL2297100T3 (pl) * 2008-05-16 2013-03-29 Lilly Co Eli Tetrahydrocyklopenta[B]indolowe modulatory receptora androgenowego
WO2010008864A2 (en) * 2008-06-24 2010-01-21 Amira Pharmaceuticals, Inc. Cycloalkane[b]indole angtagonists of prostaglandin d2 receptors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8503424D0 (en) * 1985-02-11 1985-03-13 Ici Plc Heterocyclic derivatives
DE3631824A1 (de) * 1986-02-21 1988-03-31 Bayer Ag Cycloalkano(1.2-b)indol-sulfonamide
US4814455A (en) * 1986-04-16 1989-03-21 Bristol-Myers Company Dihydro-3,5-dicarboxylates
JPS63112560A (ja) * 1986-10-29 1988-05-17 Green Cross Corp:The ジヒドロピリジン誘導体

Also Published As

Publication number Publication date
FI924167A0 (fi) 1992-09-17
NO923455D0 (no) 1992-09-04
HU9202975D0 (en) 1992-12-28
HUT63160A (en) 1993-07-28
ZA927154B (en) 1993-03-23
CA2078498A1 (en) 1993-03-21
IL103196A0 (en) 1993-02-21
FI924167A (fi) 1993-03-21
MX9205257A (es) 1993-03-01
EP0533014A1 (de) 1993-03-24
DE4131346A1 (de) 1993-03-25
AU2455592A (en) 1993-03-25
JPH07215965A (ja) 1995-08-15
NZ244394A (en) 1994-12-22
KR930006007A (ko) 1993-04-20
US5272161A (en) 1993-12-21
AU650781B2 (en) 1994-06-30
CZ286192A3 (en) 1993-04-14
CN1070397A (zh) 1993-03-31

Similar Documents

Publication Publication Date Title
IS3720A7 (is) Afleiður dialkoxy-pyridinyl-benzimidazole, aðferðvið lögun þeirra og lyfjafræðileg notkun
DE69204283D1 (de) Gelstift antiperspiranten enthaltend 2-oxazolidinon-derivate und herstellungsverfahren.
IS3823A (is) Ný carboxyl-amid efnasambönd og aðferð til framleiðslu þeirra
NO308533B1 (no) Heteroarylaminer, anvendelse derav og farmasøytisk preparat
NO882385D0 (no) Polypeptid og produksjon derav.
DE68920754D1 (de) Baugerät und Bauverfahren.
NO303446B1 (no) Nye 2-sakkarinylmetylaryl- og -aryloksyacetater, preparater og anvendelse derav
NO943794D0 (no) 4-difenylmethylpiperidinderivater, og fremgangsmåte for deres fremstilling
NO952205D0 (no) Heterocykliske karbamater, fremgangsmåte for fremstilling derav og medikamenter
IS3951A (is) Cephalosporinafleiður, aðferð til framleiðslu þeirra og notkunar sem lyfja
FI935065A (fi) Farmaceutiska foereningar
NO882562D0 (no) Nye 2-guanidino-tiazol-forbindelser fremgangsmaate for fremstilling derav og anvendelse derav.
NO932386D0 (no) Forprodukt og fremgangsmaate for fremstilling av samme
NO941517L (no) 2-amino-4-kinolin-dihydropyridiner, fremgangsmåter for deres fremstilling og deres anvendelse
NO940130D0 (no) Benzimidazolderivater, fremgangsmaate for deres fremstilling og te rapeutisk anvendelse derav
NO894532L (no) Titandioksyd, fremgangsmaate for dets fremstilling og anvendelse derav.
NO922998L (no) Perforert drivkrutt, anordning for dets fremstilling og anvendelse av anordningen
DK0492667T3 (da) 1,4-Benzothiazin-2-eddikesyrederivater, fremgangsmåder til fremstilling deraf og anvendelse deraf
NO923455D0 (no) Indolsulfonamidsubstituert dihydropyridin, fremgangsmaate for fremstilling og anvendelse i legemidler
NO923536L (no) Substituert aminopropan, fremgangsmaate for fremstilling og anvendels
DK34491A (da) Ekstruderet, biaksialt strakt skumplastroer og fremgangsmaade til fremstilling deraf
NO890522D0 (no) Substituerte imidazolinoner og imidazolinthioner.
NO924516D0 (no) Isoxazolylimidazolderivater, fremgangsmaater for fremstilling av disse, og deres anvendelse i legemidler
DK37787A (da) 2,3-dioxabicyclooe3,3,0aaoctan-derivater og deres anvendelse som laegemidler
NO901732L (no) Fremgangsmaate for fremstilling av 4-alkoksyalkyl-4-aminofenylpiperidiner og derivater derav.